NL-OMON29265Not yet recruitingNot Applicable
Arterial Reperfusion or Portal Reperfusion First in Liver Transplantation usingDonation after Circulatory Death donors
Erasmus MC Rotterdam0 sites150 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 150
Study Overview
Brief Summary
- Jay C, Ladner D, Wang E, Lyuksemburg V, Kang R, Chang Y, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - An analysis of the national registry. J Hepatol. 2011 Oct;55(4):808-13. 2. Jay CL, Lyuksemburg V, Kang R, Preczewski L, Stroupe K, Holl JL, et al. The increased costs of donation after cardiac death liver transplantation: caveat emptor. Ann Surg. 2011 Apr;251(4):743-8. 3. Jay CL, Lyuksemburg V, Ladner DP, Wang E, Caicedo JC, Holl JL, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg. 2011 Feb;253(2):259-64. 4. Farid WR, de Jonge J, Slieker JC, Zondervan PE, Thomeer MG, Metselaar HJ, et al. The importance of portal venous blood flow in ischemic-type biliary lesions after liver transplantation. Am J Transplant. 2011 Apr;11(4):857-62.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Age over 18 years of age
- •- On the active waiting list for liver transplantation
- •- Foreseen to be offered a donation after circulatory death (DCD) liver graft
- •- Written informed consent for this trial
Exclusion Criteria
- •- Contra-indications for DCD liver graft
- •- Split or reduced liver grafts
- •- Technical contra-indications to arterial reperfusion within 45 minutes (need for vascular reconstructions, jump grafting etc. during warm ischemic period)
- •- Multi-organ transplantation
- •- Pregnancy
Investigators
Similar Trials
Completed
Not Applicable
Acute Revascularization Treatment in Ischemic Stroke Patients With COVID-19Ischemic StrokeCovid19NCT04895462Centre Hospitalier Universitaire Vaudois15,128
Unknown
Not Applicable
Intermittent Portal and Graft Purge in Living Donor Liver TransplantationIschemia Reperfusion InjuryHypotensionNCT02845154Mansoura University80
Recruiting
Not Applicable
Peripheral Extreme Revascularization in "No-option" Patiens With Chronic Limb Threatening IschemiaCritical Limb-Threatening IschemiaPeripheral Arterial DiseaseDiabetic FootNCT06277362EndoCore Lab s.r.l.50
Completed
Phase 4
Prospective, Non-randomized Multi-center, Controlled Physician-initiated Trial: Rotarex Belgium In-stent OcclusionPeripheral Vascular DiseaseNCT02212626Flanders Medical Research Program30
Recruiting
Not Applicable
Revascularization for Symptomatic Non-acute Carotid Artery OcclusionNon-acute Carotid Artery OcclusionNCT06303414Xuanwu Hospital, Beijing1,000